Lerodalcibep
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lerodalcibep, covering 2025-08-03 to 2025-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH [Phase 3]